chemicals
Commented by André Will-Laudien on June 16th, 2026 | 07:25 CEST
USA–Iran: The Strait of Hormuz is Opening Up! A Sector Buy Signal for Bayer, MustGrow, BASF and K+S!
Created and published on behalf of MustGrow Biologics Corp.
Some things are ultimately not surprising. The "agreement" between the USA–Israel and Iran resembles shadow boxing. One step forward, one step back—that is how the movements at the trading desk appear. The stock markets are reacting accordingly. At the start of the week, optimism about a near-term end to the hostilities is once again dominating. Oil prices are correcting most sharply, down nearly 5%, with Brent now quoted at only USD 82.50 per barrel. This is a positive signal for chemical- and transport-oriented industries in the food sector, with BASF and Bayer showing corresponding strength. Large volumes of goods must be transported globally, and shipping routes carry significant operational importance. As part of efforts to ensure long-term food security, more and more ideas are emerging that could mitigate the international energy crisis. MustGrow focuses on natural ingredients rather than chemicals, while K+S represents a typical example of the "old economy" in this sector. For investors, multiple opportunities for returns are available!
Read
Commented by Nico Popp on June 11th, 2026 | 07:00 CEST
Secure Supply Chains for BASF and Others: Antimony Shortage Threatens Production – Antimony Resources Follows Lynas Rare Earths' Lead
Created and published on behalf of Antimony Resources Corp.
Escalating trade wars, a global supply shortage, and historic price shocks – the market for critical industrial metals is undergoing a profound transformation. Following extensive export restrictions by the People's Republic of China and a complete export ban to the US at the end of 2024, antimony prices outside China skyrocketed to an all-time high of USD 59,750 per ton. The severe imbalance between Western demand and available supply outside China led to significant supply bottlenecks in 2025—Fastmarkets recorded the sharpest price rally in the history of the antimony market that year. Since authoritarian states control around 80% of global mine production, the Western high-tech and defence industries face a potentially existential supply risk for electronic components and industrial fire-retardant applications. We explain the situation and present a potential solution.
Read
Commented by André Will-Laudien on June 2nd, 2026 | 06:55 CEST
Stock Market Rotation Beyond AI: Opportunities in MustGrow, Bayer, and Novo Nordisk; Caution with K+S
Created and published on behalf of MustGrow Biologics Corp.
A shift in perspective remains the order of the day. Yesterday, the ECB met to discuss the current situation regarding inflation and interest rates. With an inflation rate of over 3% in Europe, there is likely no room for downward interest rate adjustments—quite the opposite! The 10-year yield on German government bonds has settled near the 3% mark over the past four weeks, while in the US, the 30-year yield is already above 5%. In the past, these were warning signs for a currently well-valued NASDAQ, as the so-called trailing P/E ratio has soared from 28 to 36. Growth companies, mostly financed through equity, thrive on tech euphoria, whereas capital-intensive industries, such as the life sciences sector, face a different situation. For example, Bayer and Novo Nordisk do not require market financing, as they hold large cash reserves. In the case of K+S, the ability to pass on prices to end customers could lead to rising cash flows, while the Canadian company MustGrow has only recently raised funds and is steadily continuing its rollout in the US. Mid-term investors should focus on sector rotation when tech momentum fades. The chances of a revival in neglected sectors look strong!
Read
Commented by Armin Schulz on May 28th, 2026 | 08:30 CEST
Bayer, MustGrow Biologics, K+S: The Secret Formula for Success Behind the Biological Fertilizer Revolution
Created and published on behalf of MustGrow Biologics Corp.
The global fertilizer industry is undergoing its most significant structural transformation in generations. A growing global population, technological breakthroughs in biological agricultural solutions, and policy shifts toward more sustainable agriculture are driving this growth sector. The need for more efficient nutrient use is giving rise to a dynamic market with fresh revenue potential. Companies that pursue the right strategies now are positioning themselves for the coming decade. Three players from different worlds embody this development in their own way: Bayer, MustGrow Biologics, and K+S.
Read
Commented by Fabian Lorenz on May 27th, 2026 | 07:50 CEST
SELL BASF and Hensoldt? BUY Recommendation for Power Metallic Mines
Caution is advised with Hensoldt. Analysts see a potential 30% downside for the stock. The company is trading at a premium to industry peers such as Rheinmetall and Renk, despite slower growth. While the partnerships with Helsing and Schwarz Digits are interesting, they are unlikely to contribute significantly to revenue in the foreseeable future. In contrast, analysts see 100% upside potential for Power Metallic Mines, specifically in the base-case scenario. The first resource estimate is scheduled for this summer. According to analyst estimates, the company could thus transition from a pure exploration valuation to a resource-based valuation phase sooner than previously expected. Analysts foresee difficult times ahead for BASF. The structural problems remain unresolved, and the stock is a "Sell". The chemical giant is attempting to counter these challenges through optimization measures and the increased use of AI technologies.
Read
Commented by Armin Schulz on May 26th, 2026 | 07:35 CEST
Forget Old Batteries — BYD, HPQ Silicon, and BASF are Capitalizing on the Upcoming Megatrend
Three players from completely different sectors share a common goal: the next-generation battery. BYD dominates electric mobility, BASF leads the global chemical industry, and HPQ Silicon is poised to take the next technological leap with innovative silicon anodes. While one secures sales and the other supplies critical cathode materials, the third embodies the bet on a revolution in energy density. This unique constellation of size, industrial clout, and risk offers investors a rare early-bird opportunity. BYD, HPQ Silicon, and BASF are now truly the ones to watch.
Read
Commented by Nico Popp on May 19th, 2026 | 07:30 CEST
Bottlenecks in the Hydrogen Network: What Linde and BASF Could Learn from A.H.T. Syngas
The "green" transformation of the European chemical industry is in danger of failing. Although the Federal Network Agency approved the German core hydrogen network—which is set to grow gradually to 9,040 km of hydrogen pipelines between 2025 and 2032—the actual rollout of this critical hydrogen route is not proceeding as planned. Without the rapid expansion of key hydrogen pipelines, the industry's transformation goals are virtually unattainable. While the infrastructure is slow in coming, regulatory pressure continues to intensify under the European RED III Directive. As delays mount in large-scale infrastructure projects, energy-intensive industrial companies are increasingly being forced to explore alternative solutions. Decentralized solutions are emerging as viable options. One company that could attract growing attention from both industry players and investors is A.H.T. Syngas.
Read
Commented by Fabian Lorenz on May 13th, 2026 | 07:30 CEST
Takeover at Bayer! Shock at Rheinmetall! Opportunity for MustGrow Stock!
Created and published on behalf of MustGrow Biologics Corp.
The blockade of the Strait of Hormuz is turning into a stress test for global food security. Supply chains across the fertilizer industry are coming under pressure — and this could create a significant opportunity for MustGrow Biologics. The company's organic biological fertilizer (biofertilizer) is being approved in an increasing number of US states. And in the field of biological crop protection, they are collaborating with Bayer. Meanwhile, Rheinmetall is grappling with disappointed market expectations. Revenues at the defence contractor are simply not growing fast enough, although the company continues to modernize its product portfolio.
Read
Commented by Armin Schulz on May 7th, 2026 | 08:45 CEST
From Niche Metal to Strategic Asset: Antimony Resources Gains Relevance for Rheinmetall and BASF
Created and published on behalf of Antimony Resources Corp.
What was long considered an obscure niche metal is now critical to the defence, chemical, and energy sectors. Antimony is used to harden alloys, improve flame resistance in plastics, and support certain battery technologies. At the same time, China controls 70% of production and strictly limits its exports. The result is price spikes of over 400% within two years. Without independent sources, Western industries risk being paralyzed. This is not a theoretical scenario, but an acute reality. Reason enough to take a closer look at the defence contractor Rheinmetall, the up-and-coming antimony producer Antimony Resources, and the chemical company BASF.
Read
Commented by André Will-Laudien on May 7th, 2026 | 08:25 CEST
Moving Ahead with Strong Concepts and Easing Tensions in the Middle East! MustGrow, K+S, Evotec, and Novo Nordisk in Focus
Created and published on behalf of MustGrow Biologics Corp.
What a headline: An agreement between the US and Iran – markets up 2% in just one minute! It can happen that fast. For investors, this is welcome news, as a de-escalation in the Iran conflict would significantly ease global supply chains and reduce pressure on critical transport routes. In particular, the Strait of Hormuz would lose some of its significance as a geopolitical risk factor, potentially stabilizing global flows of goods and energy. Easing tensions are also likely to lower transport costs again, shorten delivery times, and dampen price volatility. For companies in the food, healthcare, and agricultural technology sectors, this creates greater planning certainty and new growth opportunities. MustGrow Biologics and K+S could benefit from more stable agricultural markets, while Evotec and Novo Nordisk may gain additional tailwinds in a calmer healthcare environment. Investors are increasingly turning to stocks that promise sustainable growth and reliable returns in a more stable market setting. The key question now: will volatility finally decline as well?
Read